BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of €12.20 billion as of December 5, 2025. Its market cap has increased by 205.25% in one year.

Market Cap

12.20B

Enterprise Value

13.25B

Revenue

301.53M

Ranking

n/a

PE Ratio

n/a

Stock Price

€63.44

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 12.20B, an increase of 317.66%. That is a compound annual growth rate of 24.84%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	12.35B	146.63%
Dec 31, 2024	5.01B	-21.16%
Dec 29, 2023	6.35B	496.14%
Dec 30, 2022	1.07B	-50.63%
Dec 31, 2021	2.16B	-69.70%
Dec 31, 2020	7.13B	84.61%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	242.06B
Siemens Aktiengesellschaft	175.97B
Allianz SE	141.37B
Deutsche Telekom AG	131.00B
Siemens Energy AG	97.17B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.46B
Rheinmetall AG	68.36B
Deutsche Bank Aktiengesellschaft	59.35B

Market Cap Rankings